Cargando…
The Role of Sphingolipids in Regulating Vascular Permeability in Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a disease that causes scarring and fibrotic transformation of the lung parenchyma, resulting in the progressive loss of respiratory function and, often, death. Current treatments that target profibrotic factors can slow the rate of progression but are unable to...
Autores principales: | Jayant, Girish, Kuperberg, Stephen, Somnay, Kaumudi, Wadgaonkar, Raj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296709/ https://www.ncbi.nlm.nih.gov/pubmed/37371823 http://dx.doi.org/10.3390/biomedicines11061728 |
Ejemplares similares
-
Sepsis-Associated Encephalopathy: The Blood–Brain Barrier and the Sphingolipid Rheostat
por: Kuperberg, Stephen J., et al.
Publicado: (2017) -
The Role of Sphingolipids and Ceramide in Pulmonary Inflammation in Cystic Fibrosis
por: Becker, Katrin Anne, et al.
Publicado: (2010) -
Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes
por: Clarke, Deborah L, et al.
Publicado: (2013) -
Sphingolipid Regulation of Tissue Fibrosis
por: Shea, Barry S, et al.
Publicado: (2012) -
The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)